Profile
Kean Meng Toh is currently Executive Director, Chief Scientific Officer & VP at CK Life Sciences International (Holdings), Inc. since 2018 and Director at Dogwood Therapeutics, Inc. since 2024.
Formerly, Dr. Toh was Director at Virios Therapeutics, Inc. Education includes undergraduate and doctorate degrees from the National University of Singapore and a graduate degree from the University of London.
Kean Meng Toh active positions
| Companies | Position | Start |
|---|---|---|
| CK LIFE SCIENCES INT'L., (HOLDINGS) INC. | Chief Tech/Sci/R&D Officer | 14/11/2018 |
Former positions of Kean Meng Toh
| Companies | Position | End |
|---|---|---|
Virios Therapeutics, Inc.
Virios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for fibromyalgia and other related conditions | Director/Board Member | - |
Training of Kean Meng Toh
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Virios Therapeutics, Inc.
Virios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for fibromyalgia and other related conditions | Health Technology |
CK Life Sciences International (Holdings), Inc.
CK Life Sciences International (Holdings), Inc. Pharmaceuticals: OtherHealth Technology Manufactures and markets pharmaceuticals, agriculture and nutraceuticals products | Health Technology |
National University of Singapore
National University of Singapore Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Kean Meng Toh
















